A nurse prepares a vaccine during an Ebola vaccine trial in Kampala, Uganda, on Feb. 3, 2025. Badru Katumba/AFP via Getty ImagesA global health organization said on June 1 that it is pledging about $60 million to accelerate the development of three vaccine candidates against the Bundibugyo ebolavirus, which is causing the Ebola outbreak growing in central Africa.The Coalition for Epidemic Preparedness Innovations (CEPI), an early investor in Moderna’s COVID-19 vaccine, will provide Moderna with about $50 million for preclinical testing and Phase 1 human trials of the company’s Ebola vaccine.
$60 Million Pledged to Fast-Track Ebola Vaccines
Date:
